Navigation Links
Diplomat Pharmacy Prices Its Initial Public Offering
Date:10/10/2014

FLINT, Mich., Oct. 9, 2014 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, today announced the pricing of its initial public offering of 13,333,333 shares of common stock at a price to the public of $13.00 per share. The shares are expected to begin trading on the New York Stock Exchange under the symbol "DPLO" on October 10, 2014. Diplomat is selling 10,000,000 shares of common stock and certain selling shareholders of Diplomat are selling 3,333,333 shares of common stock. The Company and selling shareholders each have granted the underwriters a 30-day option to purchase up to an additional 1,000,000 shares of common stock (an aggregate of 2,000,000 shares of common stock) to cover over-allotments, if any.

Credit Suisse Securities (USA) LLC and Morgan Stanley & Co. LLC are acting as lead book-running managers.  Additional book-running managers are J.P. Morgan Securities LLC and Wells Fargo Securities, LLC.  William Blair & Company, L.L.C. and Leerink Partners LLC are acting as co-managers.

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of any offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering is being made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, by telephone at (800) 221-1037, by facsimile at (212) 325-8057, or by email at newyork.prospectus@credit-suisse.com; or from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.

To learn more, visit diplomat.is.

About Diplomat

Diplomat serves patients and physicians in all 50 states as the nation's largest independent specialty pharmacy. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients, and the rest falls into place." Today, that tradition continues – always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is.

INVESTOR CONTACT:
Bob East, Westwicke Partners
443-213-0500

MEDIA CONTACT:
Jenny Cretu, Diplomat
810.768.9370

Logo - http://photos.prnewswire.com/prnh/20140928/148820


'/>"/>
SOURCE Diplomat Pharmacy, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Diplomat names Stephen S. Brown chief information officer
2. David Dreyer Appointed to Diplomat Board of Directors
3. Diplomat provides funding to launch Hero Town Flint, a nonprofit effort focused on area youth
4. Diplomat Marketing + Public Relations Team Receives 11 Awards from Graphic Design USA
5. Diplomat honored as a Top Innovator by Specialty Pharmacy News
6. Diplomat signs agreement with oncology management firm Physician Resource Management, Inc. as preferred specialty pharmacy network provider
7. Diplomat expands infusion specialty services with acquisition of MedPro Rx Inc.
8. Diplomat expands hemophilia specialty services with acquisition of American Homecare Federation
9. Diplomats CEO and CFO to co-present at J.P. Morgans Annual Healthcare Conference
10. Diplomat Specialty Pharmacy Honored By Inc. Magazine as One Of The Nations Fastest-Growing Companies for Fourth Consecutive Year
11. Diplomat Specialty Pharmacys 2012 Physician Satisfaction Survey Results Affirm Success of Companys Education & Training Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2019)... ... 2019 , ... The American Academy of Thermology (AAT), which is ... application of medical infrared imaging, has announced details for its 2019 Annual Meeting & ... Center in Atlanta, GA. , This is the first year that the AAT ...
(Date:2/19/2019)... Fla. (PRWEB) , ... February 19, 2019 , ... ... of Clermont, Florida, has completed his new book “Live Hard Die Young.” Dr. ... Trainers. He practices chiropractic medicine, therapeutic exercise physiology, and nutritional counseling. Dr. Oexner ...
(Date:2/16/2019)... ... 2019 , ... In observance of Gum Disease Awareness Month, ... to take their oral health seriously. With recent suggested links between gum disease ... pre-term birth, there is plenty to be concerned about along with tooth loss ...
Breaking Medicine Technology:
(Date:2/19/2019)... ... 2019 , ... In one of the first research studies ... team led by a Worcester Polytechnic Institute professor found that women who experience ... weight gain during pregnancy, and weight retention after their baby is born. , ...
(Date:2/19/2019)... ... February 19, 2019 , ... Landscape Structures Inc., a Delano, Minn.-based ... sure to be a stunning and fun addition to any play space. Spinning is ... and Curva™ Spinners will provide kids’ brains with valuable equilibrium information. , Whether park ...
(Date:2/19/2019)... ... February 19, 2019 , ... Dr. Lombardi is a ... Institute of Hope and Innovation. , Dr. Lombardi completed his undergraduate in Biochemistry ... his medical degree from the University of Rochester School of Medicine. He completed ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... of counsels to Foley & Lardner LLP, as Recognized Consultants. The CHQI Recognized ... companies, interested in pursuing CHQI accreditation. , Ms. Wein and Mr. Einhorn ...
(Date:2/19/2019)... , ... February 18, 2019 , ... ... nation to test the PathO3Gen Solutions Footwear Sanitizing Stations to maximize infection control ... TechnologyTM to kill superbugs such as MRSA and C. difficile, which can be ...
Breaking Medicine News(10 mins):